T. Rowe Price Health Sciences Fund, Inc.PRHSX
Type
Mutual fund
Peer group
US equity: Healthcare
Net assets
$10.9B
Expense ratio
0.83%
1-year return
+34.2%
3 years, a year
+12.3%
5 years, a year
+3.8%
Holdings
287
What it aims to do.
The fund seeks long-term capital appreciation.
Top 10 holdings.
| Holding | % of fund |
|---|---|
| LLY Eli Lilly & Co | 10.14% |
| TMO Thermo Fisher Scientific Inc | 4.06% |
| ISRG Intuitive Surgical Inc | 3.65% |
| SYK Stryker Corp | 3.46% |
| MRK Merck & Co. Inc. | 3.44% |
| JOBY Astrazeneca Plc | 3.17% |
| UNH Unitedhealth Group Inc | 3.09% |
| ARGX Argenx Se - Adr | 2.92% |
| ABBV Abbvie Inc | 2.84% |
| REGN Regeneron Pharmaceuticals | 2.65% |
More on PRHSX.
- PRHSX overview
- PRHSX holdings
- PRHSX risk
- PRHSX costs
- PRHSX money in and out
- PRHSX share classes
- Compare PRHSX with other funds
Returns after fees, from the fund's SEC filings up to Aug 2026. Past returns are not a promise. Not financial advice.